Olive Healthcare Core Technology
Near-infrared biomarker measurement technology
Reference technology application (450 SCI papers, 39 breast cancer papers)
* Near Infrared (NIR) Technology
NIR refers to an electromagnetic wavelength corresponding to about 780 to 2500 nm.
NIR tissue measurements have been used to measure tissue chromophores to explain the health status of humans so far, e.g., pulse oximeter.
Our real-time tissue measurements are made quantitatively in spectral regions of about 650 to 1100 nm. Our devices use the light source of 8-wavelength NIR LED (Light Emitting Diodes) to calculate oxy-hemoglobin, deoxyhemoglobin, water, and lipid by measuring tissue absorption and scattering during photon migrations.
Directly Conducted Clinical Studies
|
|
Yonsei Univ. Severance Hospital
|
Efficacy and safety of assistive diagnostic device using DMW-NIRS1) in patients with breast masses
|
Sensitivity 97.3% | Specificity 95.7% | AUC 0.99 2)
62 patients w/ lesion(# of Malignant 37 / Benign 25)
Early diagnosis of minimum 7mm malignant
Sensitive to HER-2 positive & estrogen negative
|
1) Discrete Multi-Wavelength Near-Infrared Spectroscopy
2) These results are part of a newly developed index by Olive Healthcare Inc.
|
Olive Healthcare
Core Technology
Near-infrared biomarker
measurement technology
Near-infrared biomarker measurement technology
Reference technology application
450 SCI papers, 39 breast cancer papers
* Near Infrared (NIR) Technology
NIR refers to an electromagnetic wavelength corresponding to about 780 to 2500 nm.
NIR tissue measurements have been used to measure tissue chromophores to explain the health status of humans so far, e.g., pulse oximeter.
Our real-time tissue measurements are made quantitatively in spectral regions of about 650 to 1100 nm. Our devices use the light source of 8-wavelength NIR LED (Light Emitting Diodes) to calculate oxy-hemoglobin, deoxyhemoglobin, water, and lipid by measuring tissue absorption and scattering during photon migrations.
Directly Conducted
Clinical Studies
* DMW-NIRS: Discrete
Multi-Wavelength Near-Infrared Spectroscopy
|
|
Yonsei Univ. Severance Hospital
|
Efficacy and safety of assistive diagnostic device using DMW-NIRS1) in patients with breast masses
|
Sensitivity 97.3% | Specificity 95.7% | AUC 0.99 2)
62 patients w/ lesion (# of Malignant 37 / Benign 25)
Early diagnosis of minimum 7mm malignant
Sensitive to HER-2 positive & estrogen negative
|
1) Discrete Multi-Wavelength Near-Infrared Spectroscopy
2) These results are part of a newly developed index by Olive Healthcare Inc.
|